To homepage
820К+ patients have got assistance since 2014
50 countries
1,500 clinics
6K+ reviews
3K+ qualified doctors

What's the Cost of Сarcinomatosis Diagnosis and Treatment in Republic of Korea?

Carcinomatosis treatment cost in Republic of Korea runs from $23,500 to $35,500 for advanced procedures like Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Diagnostic assessments such as a consultation with an oncologist range from $28 to $100. Total expenses depend on tumor stage, the extent of cytoreductive surgery, and the clinic tier. Patients typically find 30-50% savings compared to the US. Most specialized care is concentrated in Seoul.

Typical Сarcinomatosis Treatment Costs in Republic of Korea

  • Consultation with an oncologist: $28 – $100
  • Histopathology revision: $200 – $400
  • Extended analysis of blood: $100 – $200
  • Consultation of a radiologist: $200 – $300
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC): $23,500 – $35,500

Bookimed Expert Insight: Advanced stage patients should prioritize centers with high surgical volumes and multidisciplinary teams. Seoul National University Hospital (SNUH) reports the highest cancer treatment statistics in the country. For complex cases, Korea University Anam Hospital offers specialized robotic cancer surgery that minimizes scarring. Patients seeking top-tier digital safety benefit from the BESTcare system at Seoul National University Bundang Hospital.

Data verified by Bookimed as of August 2026, based on patient requests and official quotes from 64 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.

Your Benefits and Guarantees with Bookimed

Transparent Prices & Flexible Installments

No hidden fees – just official clinic prices. Pay at the clinic for Сarcinomatosis treatment and use a flexible installment plan if needed.

Verified Clinics & Doctors Only

Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Сarcinomatosis treatment and have the necessary licenses to serve international patients worldwide.

Free 24/7 Assistance

Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Сarcinomatosis treatment journey.

Why we?

Your personal Bookimed medical coordinator

  • Supports you at every stage
  • Helps choose the right clinic and doctor
  • Ensures quick and convenient access to information

Best Сarcinomatosis Treatment Centers in Republic of Korea: 6 Verified Options and Prices

The Bookimed clinic ranking is based on data science algorithms, providing a trusted, transparent, and objective comparison. It takes into account patient demand, review scores (both positive and negative), the frequency of updates to treatment options and prices, response speed, and clinic certifications.
Seoul National University Bundang Hospital (SNUBH)
Severance Hospital
Seoul National University Hospital (SNUH)

Get a Medical Assessment for Сarcinomatosis in Republic of Korea: Consult with Experienced Doctors Now

View all Doctors
verified

Sung Hoon Noh

Dr. Sung Hoon Noh is the Director of the Yonsei Cancer Center in Seoul. He is a primary expert in surgical treatment for advanced gastric cancer. Dr. Noh has held high-level leadership roles in international oncology societies. He works at Severance Hospital, a JCI-accredited facility ranked among the best hospitals by Newsweek.

  • Served as President of the International Gastric Cancer Association.
  • Former President of the Korean Gastric Cancer Association.
  • Recipient of the Cancer Academic Award and the Yuhan Academic Award.
  • Specializes in stomach cancer surgery, oncology, and gastroenterology.
verified

Lee, Han-Byoel

The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.

verified

Kim Jin

23 years of experience

Dr. Kim Jin is a colorectal surgeon at Korea University Anam Hospital in Seoul. He is the Vice President of the Korean Association of Robotic Surgeons. Dr. Kim represents South Korea on the board of the Asia Pacific Endo-Lap Surgery Group. He performs surgical demonstrations for medical faculties in Hong Kong and Singapore.

  • Directs the Training and Education Committee at the Korean Surgical Society.
  • Sits on the Surgical Affairs Board of the Korean Society of Gastroenterology.
  • Serves as Director of IT for the Korean Society of Coloproctology.
  • Practices at a JCI-accredited hospital ranked among the world’s best by Newsweek.

Share this content

Video Stories from Bookimed Patients

Dayana
I combined my vacation in Antalya with a check-up.
Procedure: Female check-up
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedure: Dental Implant
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedure: Female check-up
Updated: 05/27/2022
Authored by
Anna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
Fahad Mawlood
Medical Editor & Data Scientist
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Fahad Mawlood Linkedin
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Expert Overview about Сarcinomatosis Treatment in Republic of Korea

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

What are the primary treatments for carcinomatosis offered in Korean hospitals?

South Korean hospitals treat carcinomatosis using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Major centers in Seoul combine these with systemic chemotherapy and robotic-assisted procedures. JCI-accredited facilities focus on multimodal approaches for gastric, colorectal, and ovarian cancer metastasis to improve survival outcomes.

  • Cytoreductive surgery: Surgeons remove all visible tumor implants from the peritoneal cavity.
  • HIPEC protocol: Heated chemotherapy circulates in the abdomen after surgery to kill cells.
  • Systemic chemotherapy: Drug therapy reduces tumor burden before or after surgical intervention.
  • Robotic-assisted surgery: Specialized centers use robotic systems for precise, minimally invasive tumor removal.

Bookimed Expert Insight: While most assume surgery is the first step, Korean university hospitals often prioritize 318,000+ annual oncology procedures. Data shows leading centers like Seoul National University Hospital use digital tracking to prevent errors. Choosing a facility with over 65,000 operations yearly ensures access to the highest surgical expertise for complex peritoneal cases.

Patient Consensus: Patients note that Korean surgeons carefully evaluate imaging and pathology before approving aggressive surgery. It is important to confirm if the hospital offers the CRS and HIPEC combination for your specific cancer type.

What is the success rate and survival outcome of CRS+HIPEC in Korea?

Korean tertiary centers achieve nearly 77% optimal debulking rates for peritoneal carcinomatosis. Complete cytoreduction (CC-0) occurs in 59% of cases. Median survival for colorectal metastasis reaches 35 months. Specialized facilities like Asan Medical Center perform over 65,000 surgeries annually with high technical precision.

  • Optimal debulking: Success in removing all visible disease reaches approximately 77% in selected cohorts.
  • Survival outcomes: Colorectal cancer patients show a median survival time of up to 35 months.
  • Gastric cancer: Low disease burden cases potentially reach a 24-month median survival period.
  • High-grade safety: Major complications are limited to 12% at top-tier Korean referral centers.

Bookimed Expert Insight: Korea's infrastructure favors complex cases due to extreme digitalization and high patient volumes. Clinics like Seoul National University Bundang Hospital use the BESTcare system to minimize surgical errors. With Severance Hospital seeing 1.6 million outpatients annually, surgeons maintain high proficiency in cytoreduction. This surgical density directly correlates with the 77% optimal debulking rate reported in local studies.

Patient Consensus: Patients note that Korean surgeons focus heavily on complete cytoreduction as the primary predictor of survival. Recovery often involves significant fatigue and weight loss during the first few months after surgery.

Which hospitals are considered the best for peritoneal carcinomatosis in Korea?

Top Korean hospitals for peritoneal carcinomatosis include Asan Medical Center, Severance Hospital, and Seoul National University Hospital. These JCI-accredited facilities specialize in cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). They consistently rank among the World's Best Hospitals by Newsweek for oncology excellence.

  • Asan Medical Center: Performs over 65,000 operations annually as South Korea's largest multidisciplinary hospital.
  • Severance Hospital: Features 13 specialized cancer centers and maintains Joint Commission International accreditation.
  • Seoul National University Hospital: Reports the highest oncology treatment statistics among leading state facilities.
  • Korea University Anam Hospital: Specializes in advanced robotic cancer surgery and complex abdominal oncology.

Bookimed Expert Insight: Data shows a clear volume-based quality trend in Seoul. Asan Medical Center manages over 10,000 daily outpatients. This massive volume allows their surgical teams to specialize exclusively in peritoneal surface malignancies. For complex HIPEC procedures, this specific repetition often leads to better surgical precision than general oncology wards.

Patient Consensus: Patients note that choosing a surgeon with high case volumes for your specific cancer type is vital. They emphasize checking if the hospital has a dedicated peritoneal malignancy team rather than just a general oncology department.

How long is the recommended stay in Korea for the complete CRS+HIPEC treatment cycle?

The recommended stay in the Republic of Korea for CRS and HIPEC is 14 to 21 days. This window covers complex 8-hour surgery and necessary hospitalization. You must remain until stable for long-haul travel. Most patients stay in the hospital for 10 to 14 days.

  • Hospitalization period: Inpatient care typically lasts 10 to 21 days for monitoring.
  • Surgical duration: Expect the procedure to take approximately 8 hours on average.
  • Recovery timeline: Full physical recovery generally requires 3 months after returning home.
  • Clinical volume: Top centers like Severance Hospital treat over 1,000,000 patients annually.

Bookimed Expert Insight: Korea's major centers like Asan Medical Center and SNUH operate at massive scale, managing thousands of patients daily. This high volume means post-surgical protocols are extremely standardized. We notice that patients often need 3 to 5 extra days in a nearby hotel after hospital discharge. This buffer ensures you are eating and walking well before a long flight.

Patient Consensus: Patients emphasize that regain of bowel function and hydration levels determines when you can actually fly. They recommend booking flexible return tickets because recovery speed varies significantly between individuals.

Are English-speaking doctors and support services available for international patients?

South Korean specialty hospitals provide English-speaking doctors and dedicated coordinators for international carcinomatosis patients. Leading centers in Seoul maintain JCI-accredited departments specifically for medical tourists. These teams handle appointment logistics, medical translations, and multidisciplinary coordination for complex treatments like HIPEC.

  • International departments: Dedicated offices at SNUBH and Severance coordinate all logistics.
  • Language support: English-speaking coordinators facilitate consultations between patients and oncology specialists.
  • Accreditation standards: Facilities like Asan Medical Center hold Global Healthcare Accreditation (GHA).
  • Documentation: Major Seoul hospitals provide English-language medical reports and pathology results.

Bookimed Expert Insight: While top oncologists often speak English, the high volume at clinics like Asan Medical Center—serving 11,800 outpatients daily—makes the dedicated international coordinator essential. These staff members ensure your HIPEC protocol details aren't lost in translation during busy shifts. Check if your chosen clinic has JCI or GHA accreditation to guarantee these communication standards.

Patient Consensus: Patients note that while lead surgeons often have high fluency, navigating nursing care and billing requires the hospital's dedicated translation support. Most recommend confirming a personal coordinator is assigned before traveling for intensive cancer treatments.

What are the most effective treatments for carcinomatosis in South Korea?

South Korean specialist centres treat carcinomatosis using cytoreductive surgery paired with hyperthermic intraperitoneal chemotherapy. Major Seoul hospitals lead this field with multidisciplinary teams. These centres report a 17% five-year survival rate for colorectal peritoneal metastasis. Board-certified oncologists use robotic systems to improve surgical precision.

  • Multidisciplinary approach: Surgeons and oncologists combine cytoreductive surgery with heated chemotherapy.
  • Robotic precision: Centres like Severance Hospital use Da Vinci systems for complex abdominal procedures.
  • Advanced diagnostics: Clinics use PET-CT and histopathology revision to map tumour spread accurately.
  • Specialised units: Asan Medical Center operates a dedicated team for peritoneal metastasis cases.

Bookimed Expert Insight: Most Australian patients overlook that South Korea's top hospitals, like Seoul National University Hospital, achieve 90% success rates in complex GammaKnife procedures. For carcinomatosis, the real advantage is the high volume. Major centres treat over 1 million patients annually, so surgeons have handled virtually every variation of peritoneal spread. This leads to highly refined surgical techniques.

Patient Consensus: Patients note that care at major Republic of Korea university hospitals is fantastic and well organised. They recommend bringing full pathology records as clinics usually re-confirm every diagnosis before starting intensive systemic therapy.

Why should I choose South Korea for carcinomatosis treatment?

South Korea offers superior carcinomatosis outcomes. This is due to 5-year cancer survival rates that often exceed Western benchmarks. Leading Seoul hospitals provide advanced cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). These centres hold Joint Commission International (JCI) accreditation and feature highly experienced multidisciplinary oncology teams.

  • Specialised procedures: Clinics provide HIPEC therapy to treat cancer that has spread to the peritoneum.
  • Robotic expertise: Severance Hospital has performed over 4,000 robotic surgeries. This improves precision and recovery times.
  • Rapid diagnostics: Korea University Anam Hospital offers same-day consultations, testing, and admission for new patients.
  • Clinical partnerships: Severance Hospital oncology teams collaborate with top-tier US institutions like MD Anderson.
  • Accredited facilities: Major centres like Asan Medical Center hold both KOIHA and ISO international certifications.

Bookimed Expert Insight: South Korea is a global powerhouse for complex abdominal cancers. Seoul National University Hospital achieves an 86.5% anus preservation rate in colon surgery. This significantly outperforms many leading Western clinics. Patients with carcinomatosis benefit from this extreme surgical volume. Centres like Asan Medical Center perform over 65,000 operations annually. This leads to highly refined techniques.

Patient Consensus: Patients praise the accessibility and fast diagnostic speeds in Republic of Korea hospitals. This stands out against England or Australia. They highlight that language barriers exist. However, the ability to get immediate scans and specialist results makes Korea a premier medical destination.

Which are the top hospitals for cancer treatment in South Korea?

Three hospitals lead cancer treatment in South Korea. They are Asan Medical Center, Severance Hospital, and Seoul National University Hospital (SNUH). These Seoul-based hospitals hold JCI or KOIHA accreditations. They offer therapies like HIPEC, robotic surgery, and proton beam therapy. Most report oncology survival rates exceeding international averages.

  • Seoul National University Hospital: achieves a 91.9% breast cancer survival rate using digital systems.
  • Asan Medical Center: South Korea’s largest hospital, performing over 65,000 surgeries every year.
  • Severance Hospital: collaborates with MD Anderson and performs over 4,000 robotic surgeries.
  • Korea University Anam Hospital: offers same-day consultation and admission for new oncology patients.

Bookimed Expert Insight: Major centres like Asan and Severance handle the highest volumes. Korea University Anam Hospital provides a significant advantage for international travellers. Their protocol allows for same-day consultation, testing, and admission. This speed is vital for complex cases like carcinomatosis. Treatment delays must be avoided.

Patient Consensus: Patients describe the oncology care in Seoul as fantastic. They often find it comparable to top-tier Western institutions. Many highlight the ease provided by international patient offices. These offices coordinate English communication and rapid pathology scans.

What diagnostic tools are used to prepare for carcinomatosis treatment in South Korea?

South Korean cancer centres prepare for carcinomatosis treatment using high-precision tools. These tools include 3.0 Tesla MRI, PET-CT, and exploratory laparoscopy. These diagnostics assess peritoneal spread to plan surgeries like HIPEC. Specialists prioritise histopathology revisions and genomic profiling to tailor chemotherapy protocols for each patient.

  • Advanced imaging: PET-CT and 3.0 Tesla MRI detect small peritoneal implants and distant metastases.
  • Exploratory laparoscopy: Surgeons use minimally invasive cameras to identify occult spread not visible on scans.
  • Pathology revision: Experts review existing biopsy slides and immunohistochemistry to confirm the primary cancer source.
  • Tumour markers: Blood tests measuring CEA and CA-125 help assess the overall disease burden.
  • AI diagnostics: Centres use AI-powered software to improve the detection of metastatic lesions in radiology.

Bookimed Expert Insight: Major Seoul centres like Asan Medical Center and Severance Hospital often perform over 40,000 surgeries annually. This massive volume allows radiologists to specialise exclusively in peritoneal surface malignancies. Their expertise in reading 3.0 Tesla MRI scans often identifies tiny nodules. These nodules, missed by standard imaging, are critical for HIPEC eligibility.

Patient Consensus: Patients recommend sending pathology slides and recent scans beforehand. This allows Korean specialists to review diagnostic materials and confirm the treatment plan. They can do this before the patient travels to Seoul.

What is the process for international patients seeking carcinomatosis treatment in South Korea?

International patients follow a structured pathway for carcinomatosis care in South Korea. The process starts with a records review. It moves through diagnostic staging, visa assistance, and specialised surgery like HIPEC. Facilities such as Severance Hospital and Asan Medical Center use JCI-accredited protocols for global patients.

  • Record submission: Centres review original pathology slides, CT scans, and blood results before travel.
  • Visa assistance: Accredited hospitals provide invitation letters for required C-3-3 or G-1-10 medical visas.
  • Staging tests: Specialists often perform repeat PET-CT and blood work to confirm the diagnosis.
  • HIPEC treatment: Leading centres use Hyperthermic Intraperitoneal Chemotherapy to treat cancer spread within the abdomen.

Bookimed Expert Insight: Major university hospitals like Korea University Anam Hospital offer same-day consultations and testing. This is for new cancer patients. This speed is vital for carcinomatosis. Choosing these high-volume centres allows patients to access multidisciplinary teams. These teams often handle over 20,000 surgeries monthly, making staff experts in complex cases.

Patient Consensus: Patients recommend contacting international teams at large Seoul university hospitals to access English-speaking staff. They suggest bringing written questions and physical biopsy slides to South Korea. This avoids treatment delays.

Get a free consultation

Select the best way to contact you